Bristol-Myers upgraded to overweight

Analysts at Morgan Stanley lifted their rating on Bristol-Myers Squibb Company (BMY) to “overweight” from “equal weight”.

Stocks rise on Trump day

Stocks are higher this Friday morning as the world prepares for the inauguration of President Trump. The price of oil… Read More >